Use of enoxaparin for performimg percutaneous coronary intervention

Details for Australian Patent Application No. 2006286244 (hide)

Owner Aventis Pharma S.A.

Inventors Not Given

Agent Watermark

Pub. Number AU-A-2006286244

PCT Pub. Number WO2007/026265

Priority 60/713329 02.09.05 US

Filing date 4 September 2006

Wipo publication date 8 March 2007

International Classifications

A61K 31/4365 (2006.01)

A61K 31/616 (2006.01)

A61K 31/727 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/026265 Priority application(s): WO2007/026265

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006286277-Direct aminolysis

2006286239-Aromatic pocket tear tape for cigarette pack